Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon May 04, 2023 9:35am
116 Views
Post# 35429655

RE:RE:RE:RE:New trial update on FDA/Multiple melanoma

RE:RE:RE:RE:New trial update on FDA/Multiple melanoma

My feelings not hurt at all.
spelling for me has been a life long challenge.
that said, I read extremely fast & significant vocabulary.
I have been called direct names from people on various boards. Somewhat meaningless as they have no idea who I am or anything about me.
I try very hard to post exact, real traceable information about Onc.
One guy called me a liar & a cheat, because I noted the wrong date. ( by one day).
THAT, is total silliness.
There are a few on here who know my personally. 
Back to onc: Tomorrow there will be a N.R. Early, before the 8:30 Q1 update.
There are the very upfront phase 2, pancreatic & MBc cancers, with FDA " fast track" designation.
plus, the M.M. And .......Irene triple neg breast cancer with Incyte, 
and the whole Goblet study with Roche.
Last but not least the CAR-T, is expecting to have updates Q2, that being between now & June.
Lots of reasons to look to a positive future
regards
 

<< Previous
Bullboard Posts
Next >>